Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00952081 · ClinicalTrials.gov registry record · Phase 4
A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT00952081 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 22 participants.
The verdict
NCT00952081, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
This protocol describes a study to gain experience in the use of Clevidipine for perioperative blood pressure control in patients undergoing craniotomy for brain tumor or epilepsy focus resection. The purpose of this study is to establish the efficacy of Clevidipine for intraoperative blood pressure control in patients undergoing intracranial procedures, and gather information on the dosage and adverse effects of Clevidipine in neurosurgical patients. This initial pilot experience serves to familiarize the investigators with the use of this drug prior to initiating a planned randomized trial versus institutional standard-of-care therapy. The investigators will obtain greater familiarity with the dosing of clevidipine in this patient population and collect information on the incidence of adverse effects.
Interventions
- DRUG Clevidipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00952081
The ClinicalTrials.gov registry entry for NCT00952081 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clevidipine is the first listed.
NCT00952081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00952081 about?
NCT00952081 is a clinical study titled "A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients". This protocol describes a study to gain experience in the use of Clevidipine for perioperative blood pressure control in patients undergoing craniotomy for brain tumor or epilepsy focus resection. The purpose of this study is to establish the efficacy of Clevidipine for intraoperative blood pressure...
What is the current status of trial NCT00952081?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2009-07. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00952081?
The interventions under investigation include: Clevidipine (DRUG).
Who is sponsoring clinical trial NCT00952081?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.